Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
Thursday, September 05, 2013
Merck, known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines ...
read more
Wednesday, September 30, 2015
Merck expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
read more
Wednesday, March 20, 2019
Merck and NGM announced Merck has exercised its option to extend the research phase of the companies’ collaboration for an additional two-year period to March 2022.
read more
Thursday, December 27, 2018
Merck has announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
read more
Tuesday, November 16, 2021
Merck announced that it will support SaudiVax Ltd., based in the Kingdom of Saudi Arabia, to design a best-in-class, multi-modality manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region.
read more
Merck, a leading science and technology company, will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs' monoclonal antibody in late stage clinical development.
read more
Themis and Merck announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately-held Themis.
read more
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per ...
read more
Merck Serono, a division of Merck in Darmstadt, Germany, announced today a first employment initiative for its employees affected by the restructuring of its operations in Switzerland. Quintiles, the world's leading biopharmaceutical services company...
read more
Wednesday, August 19, 2015
Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked.
read more
Merck announced the opening of its first joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.
read more
Friday, September 22, 2017
Merck has announced the opening of its first BioReliance End-to-End Biodevelopment Center in the Asia Pacific region.
read more
Tuesday, January 07, 2014
The German pharmaceutical, chemical and
life science company Merck KGaA, Darmstadt, Germany, broke ground today on a new
production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility,
which is estimated to cost nearly € ...
read more